Christopher Weyrer M.D.

Christopher Weyrer, MD, PhD, currently serves as Chief Business Officer at Protego Biopharma and holds advisory roles at LB Pharmaceuticals, Inc. and Vida Ventures, LLC. With extensive experience at Capstan Therapeutics and Kyverna Therapeutics as a Board Observer, Christopher has contributed to science and technology committees and operational initiatives. Previously, at Boston Consulting Group, Christopher led projects on R&D strategy and operations in biopharma, global health, and MedTech. Christopher's academic background includes a dual PhD in Neuroscience from Harvard Medical School and the University of Cambridge, along with an MD from the Medical University of Vienna and a BSc in Physics.